The association of vascular access flow with sacubitril/valsartan and left ventricular ejection fraction in hemodialysis patients with heart failure with reduced ejection fraction
In HD patients with HFrEF, treatment with sacubitril/valsartan is associated with improvement in LVEF and Qa over 12 months.
Authors
- Shuo‐Ming Ou (ORCID: https://orcid.org/0000-0003-0693-3728)
- Kuo‐Hua Lee (ORCID: https://orcid.org/0000-0002-6314-8788)
- Ming‐Tsun Tsai (ORCID: https://orcid.org/0000-0002-8597-4132)
- Yun‐Ching Fu (ORCID: https://orcid.org/0000-0003-1075-0975)
- Chih‐Yu Yang (ORCID: https://orcid.org/0000-0001-9899-3159)
- Tzu‐Chieh Lin (ORCID: https://orcid.org/0000-0002-6542-2023)
- Chyong‐Mei Chen (ORCID: https://orcid.org/0000-0001-6824-4819)
- Chih‐Wei Tseng (ORCID: https://orcid.org/0000-0002-6951-4646)
- Ann Charis Tan (ORCID: https://orcid.org/0000-0002-7776-5613)
- Zih-Kai Kao (ORCID: https://orcid.org/0000-0002-1662-3873)
- Szu‐Yuan Li (ORCID: https://orcid.org/0000-0002-3639-8212)
- Fan-Yu Chen
Institutions
- National Yang Ming Chiao Tung University (TW)
- Taipei Veterans General Hospital (TW)
- Smart Software (Czechia) (CZ)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2025-03-25
- DOI
- https://doi.org/10.1093/ckj/sfaf078
- Primary Topic
- Central Venous Catheters and Hemodialysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Taipei Veterans General Hospital